manufacturer,submission_id,submission_title,stage_of_development,target_pathogen,region,permalink,regulatory_status,other_regulatory_status,planned_market_entry,primary_use_case,type_of_technology,assay_aim,assay_target,target_analyte,technology_principle,readout_technology,resistance_marker,test_format,other_test_format,instrument_requirement,level_of_automation,lab_vs_poc,self_testing_self_collection,validated_sample_types,other_validated_sample_type,time_to_results_excl_prep,test_to_be_listed_on_finds_web_page,data_to_be_published_on_finds_web_page,drug_resistance_target,other_drug_resistance_target,target_patient_group,sensitivity,sensitivity_ci_low,sensitivity_ci_up,specificity,specificity_ci_low,specificity_ci_up,total_number_samples,regex,country
Ustar Biotechnologies (Hangzhou) Ltd.,a2r69000007lbFN,Diagnostic Kit for Mycobacterium Tuberculosis (TB) DNA,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://en.bioustar.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,Unknown,Isothermal NAT(other),Unspecified,Not applicable,Cartridge-based processing,NA,No instrumentation is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
Abbott Molecular,a2r69000007lbEm,Determine TB-LAM Ag,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Not applicable,NA,Active TB,42.00%,31.00%,55.00%,91.00%,85.00%,95.00%,3449,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Abbott Molecular,a2r69000007lbEm,Determine TB-LAM Ag,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Not applicable,NA,Active TB,42.00%,31.00%,55.00%,91.00%,85.00%,95.00%,3449,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Abbott Molecular,a2r69000007lbEm,Determine TB-LAM Ag,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Not applicable,NA,Active TB,35.00%,22.00%,50.00%,95.00%,89.00%,98.00%,3365,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Abbott Molecular,a2r69000007lbEm,Determine TB-LAM Ag,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Not applicable,NA,Active TB,52.00%,40.00%,64.00%,87.00%,78.00%,93.00%,2253,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Abbott Molecular,a2r69000007lbEm,Determine TB-LAM Ag,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Not applicable,NA,Active TB,29.00%,17.00%,47.00%,96.00%,91.00%,99.00%,1196,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Abbott Molecular,a2r69000007lbEm,Determine TB-LAM Ag,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Not applicable,NA,Active TB,62.00%,41.00%,83.00%,84.00%,48.00%,96.00%,537,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Abbott Molecular,a2r69000007lbEm,Determine TB-LAM Ag,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Not applicable,NA,Active TB,31.00%,18.00%,47.00%,95.00%,87.00%,99.00%,2828,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
R-Biopharm AG,a2r69000007lb91,IP-10 IGRA LF,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Europe,https://r-biopharm.com,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,Unspecified,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,near Point of Care,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
R-Biopharm AG,a2r69000007lbFH,IP-10 IGRA ELISA,Research Use Only (RUO),Mycobacterium Tuberculosis,Europe,https://r-biopharm.com,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,heprin,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
SD BIOSENSOR INC,a2r69000007lbFL,STANDARD E TB-Feron ELISA,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://sdbiosensor.com,CE-IVDD; Korea MFDS,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Plasma,NA,100,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Autogenomics,a2r69000007lbEo,INFINITIMTB Assay,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://autogenomics.com/?q=node/42,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,katG; pncA; rpoB,Cartridge-based processing,microarray chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Unknown,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Bioneer Corporation,a2r69000007lbF6,MDR/XDR multi-test kit,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://bioneer.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,Unknown,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Sputum,NA,60,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,99.70%,98.40%,99.90%,98.50%,91.90%,99.70%,417,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,76.10%,67.60%,82.90%,98.80%,97.50%,99.40%,679,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,85.00%,82.00%,88.00%,98.00%,97.00%,98.00%,37237,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,98.00%,97.00%,98.00%,0.00%,0.00%,0.00%,18275,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,67.00%,62.00%,72.00%,98.00%,98.00%,99.00%,18962,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Rifampicin,NA,Active TB,96.00%,94.00%,97.00%,98.00%,98.00%,99.00%,8020,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,99.70%,98.40%,99.90%,98.50%,91.90%,99.70%,417,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,76.10%,67.60%,82.90%,98.80%,97.50%,99.40%,679,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,85.00%,82.00%,88.00%,98.00%,97.00%,98.00%,37237,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,98.00%,97.00%,98.00%,0.00%,0.00%,0.00%,18275,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,67.00%,62.00%,72.00%,98.00%,98.00%,99.00%,18962,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Rifampicin,NA,Active TB,96.00%,94.00%,97.00%,98.00%,98.00%,99.00%,8020,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,99.70%,98.40%,99.90%,98.50%,91.90%,99.70%,417,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,76.10%,67.60%,82.90%,98.80%,97.50%,99.40%,679,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,85.00%,82.00%,88.00%,98.00%,97.00%,98.00%,37237,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,98.00%,97.00%,98.00%,0.00%,0.00%,0.00%,18275,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Not applicable,NA,Active TB,67.00%,62.00%,72.00%,98.00%,98.00%,99.00%,18962,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb94,Xpert MTB/RIF,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB rpoB gene,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Rifampicin,NA,Active TB,96.00%,94.00%,97.00%,98.00%,98.00%,99.00%,8020,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb95,Xpert MTB/RIF Ultra,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,60,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb95,Xpert MTB/RIF Ultra,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,60,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Isoniazid,NA,Active TB,95.20%,92.90%,96.80%,95.60%,90.10%,98.10%,596,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Fluoroquinolone,NA,Active TB,94.50%,90.70%,96.90%,95.20%,92.50%,96.90%,594,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Amikacin,NA,Active TB,87.70%,77.50%,93.60%,98.50%,97.00%,99.20%,593,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Kanamycin,NA,Active TB,93.70%,89.00%,96.40%,92.40%,89.40%,94.60%,594,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Capreomycin,NA,Active TB,75.40%,64.00%,84.00%,99.60%,98.60%,99.90%,595,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Ethionamide,NA,Active TB,55.00%,49.50%,60.30%,93.80%,90.30%,96.10%,597,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb95,Xpert MTB/RIF Ultra,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,qPCR,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,60,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Oxford Immunotec Limited,a2r69000007lbFE,T-SPOT.TB,Regulatory Achieved,Mycobacterium Tuberculosis,Europe,https://oxfordimmunotec.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,MTB CFP-10; MTB ESAT-6,ELISA/EIA,Colorimetric,Not applicable,Unspecified,NA,A proprietary/new instrument is optional,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?kingdom|britain|^u\.?k\.?$,United Kingdom
Abbott Molecular,a2r69000007lbLJ,Abbott RealTime MTB,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB IS6110; MTB pab gene,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Abbott Molecular,a2r69000007lb6C,Abbott RealTIme MTB RIF/INH,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,NA,Yes,Yes,Rifampicin,NA,Active TB,94.80%,88.30%,98.30%,100.00%,97.00%,100.00%,216,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Abbott Molecular,a2r69000007lb6C,Abbott RealTIme MTB RIF/INH,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://abbottmolecular.com/home.html,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,NA,Yes,Yes,Isoniazid,NA,Active TB,88.30%,80.00%,94.00%,94.30%,88.60%,97.70%,217,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
BD Molecular Diagnostics,a2r69000007lbEr,BD Max MDR-TB,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://moleculardiagnostics.bd.com,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,qPCR,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Other,Sputum Sediment,240,Yes,Yes,Not applicable,NA,Active TB,94.50%,91.70%,96.40%,94.90%,91.10%,97.10%,596,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
BD Molecular Diagnostics,a2r69000007lbEr,BD Max MDR-TB,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://moleculardiagnostics.bd.com,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,qPCR,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Other,Sputum Sediment,240,Yes,Yes,Rifampicin,NA,Active TB,100.00%,87.10%,100.00%,100.00%,98.20%,100.00%,232,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
BD Molecular Diagnostics,a2r69000007lbEr,BD Max MDR-TB,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://moleculardiagnostics.bd.com,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,qPCR,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Other,Sputum Sediment,240,Yes,Yes,Isoniazid,NA,Active TB,100.00%,91.80%,100.00%,100.00%,98.10%,100.00%,242,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Bioneer Corporation,a2r69000007lbEs,AccuPower TB&MDR RealTime PCR kit-A,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,fabG1; inhA; katG; oxyR-ahpC intergenic region; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Bioneer Corporation,a2r69000007lbEs,AccuPower TB&MDR RealTime PCR kit-A,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,fabG1; inhA; katG; oxyR-ahpC intergenic region; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Bioneer Corporation,a2r69000007lbF4,AccuPower XDR-TB RealTime PCR kit-A,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Bioneer Corporation,a2r69000007lbF4,AccuPower XDR-TB RealTime PCR kit-A,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Bioneer Corporation,a2r69000007lbF5,AccuPower XDR-TB RealTime PCR kit-B,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,embB; rpsL,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Bioneer Corporation,a2r69000007lbF5,AccuPower XDR-TB RealTime PCR kit-B,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,embB; rpsL,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Serum Institute of India,a2r69000007lbFM,C-Tb skin test,Research Use Only (RUO),Mycobacterium Tuberculosis,Asia,https://seruminstitute.com,Unknown,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,MTB CFP-10; MTB ESAT-6,Host Immune Response,Colorimetric,Not applicable,Other,Injectable,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Other,injection under skin,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,india(?!.*ocea),India
SD BIOSENSOR INC,a2r69000007lbLA,TB LAM assay,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://sdbiosensor.com,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Salus Discovery,a2r69000007lbFJ,FLOW TB,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,North America,https://salusd.com globalaccessdx.com,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
"Atlas Link Technology Co., Ltd.",a2r69000007lbLH,NOVA Test Tuberculosis IGG/IGM Tri-line Test,Research Use Only (RUO),Mycobacterium Tuberculosis,Asia,https://atlas-link.com,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antibody (serological),MTB IgG; MTB IgM,Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Plasma; Serum; Whole Blood,NA,15,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Atlas Link Technology Co., Ltd.",a2r69000007lbLI,NOVA Test Tuberculosis Antibody Test,Research Use Only (RUO),Mycobacterium Tuberculosis,Asia,https://atlas-link.com,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antibody (serological),Unknown,Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Serum,NA,15,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.,a2r69000007lbLK,Recombinant mycobacterium tuberculosis fusion protein(EC)n,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://zflongkema.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,PPD tuberculin,Host Immune Response,Colorimetric,Not applicable,Other,Injectable,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Other,injection under skin,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
Antrum Biotech,a2r69000007lbLL,IRISA-TB,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Africa,https://antrumbiotech.co,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Cerebrospinal fluid (CSF); Other,Pleural fluid; Pericardial fluid; Peritoneal fluid;,120,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,south.africa|s\\..?africa,South Africa
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lb6F,MeltPro MTB/RIF Test Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,rpoB,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lb6B,MeltPro MTB/SL Test Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://zeesandx.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,eis promoter; rrs,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lb6H,MeltPro MTB/INH Test Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,inhA; inhA promoter; oxyR-ahpC intergenic region,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lb6G,MeltPro MTB/STR Test Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,rpsL,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lb6J,MeltPro MTB/FQ Test Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,gyrA,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lb6I,MeltPro MTB/EMB Test Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,embB,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lbFP,MeltPro Mycobacteria Identification Kit,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://zeesandx.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB ITS,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lbFO,MeltPro TB Assay,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://zeesandx.com,Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB IS6110,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Xiamen Zeesan Biotech Co., ltd.",a2r69000007lbFQ,MeltPro Mycobacterium Tuberculosis McSpoligotyping Kit,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://zeesandx.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,Other,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
Mikrogen GmbH,a2r69000007lb8t,T-Track TB part 2 - T-Track TB Quant PCR,Regulatory Achieved,Mycobacterium Tuberculosis,Europe,https://mikrogen.de,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,RNA,Interferon Gamma; Other,qPCR,Fluorescence,Not applicable,NAT reagent kit (open source),NA,A proprietary/new instrument is optional,Manual,Lab-based,Intended for professional use only,Purified RNA,NA,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Research Center Borstel,a2r69000007lb8w,TB22 signature in-house assay,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,Europe,https://fz-borstel.de/index.php/en,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Immunoassay,ID,RNA,Unknown,qPCR,Fluorescence,Not applicable,Unspecified,NA,Unknown,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
QuantuMDx Group Limited,a2r69000007lb8z,RISK 6 host response assay,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,Europe,https://quantumdx.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Immunoassay,ID,RNA,Unknown,qPCR,Fluorescence,Not applicable,Unspecified,NA,Unknown,Unknown,Lab-based,Intended for professional use only,Finger prick blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?kingdom|britain|^u\.?k\.?$,United Kingdom
Wyss Institute,a2r69000007lbLD,Single-Molecule Immunoassay for Triaging Tuberculosis,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,North America,https://wyss.harvard.edu,Unknown,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM); Other,Unspecified,Fluorescence,Not applicable,Unspecified,NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Mikrogen GmbH,a2r69000007lbEy,T-Track TB part 1 - T-Track TB Stimulation,Regulatory Achieved,Mycobacterium Tuberculosis,Europe,https://mikrogen.de,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,MTB CFP-10; MTB ESAT-6,Other,Fluorescence,Not applicable,Other,Stimulation/incubation,A proprietary/new instrument is optional,Manual,Lab-based,Intended for professional use only,Whole Blood,Blood stimulation tubes,1440,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
GenEndeavor llc,a2r69000007lbL8,RidTB,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,North America,https://Genendeavor.com,None,NA,Unknown,Triage/Screening,Molecular,ID,DNA,MTB IS6110,Other,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,Standard lab instrumentation is required,Manual,near Point of Care,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Erythra Inc.,a2r69000007lb8p,Erythra-TB-KIT,Research Use Only (RUO),Mycobacterium Tuberculosis,Asia,http://www.genenexus.com/,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Other,Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,near Point of Care,Intended for professional use only,Other,Heamolysate,5,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
EMPE Diagnostics,a2r69000007lbFB,floDx miniMDR-TB,Regulatory Status Unknown,Mycobacterium Tuberculosis,Asia,https://empediagnostics.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB ITS,Other,Colorimetric,inhA; katG; rpoB,Rapid diagnostic test (strip or cassette),NA,Standard lab instrumentation is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,india(?!.*ocea),India
EMPE Diagnostics,a2r69000007lb8o,floDx pre-XDR-TB,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://empediagnostics.com,None,NA,2023,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB ITS,Other,Colorimetric,gyrA; inhA; katG; rpoB,Rapid diagnostic test (strip or cassette),NA,Standard lab instrumentation is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,india(?!.*ocea),India
"Eiken Chemical Co., Ltd.",a2r69000007lb8j,LoopampTM MTBC Detection Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://eiken.co.jp,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB gyrB Gene; Other,Isothermal LAMP,Fluorescence,Not applicable,NAT reagent kit (open source),NA,Standard lab instrumentation is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,40,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,japan,Japan
Conservation X Labs,a2r69000007lbF8,Nucleic Acid Identification Tool (NABIT),Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,North America,https://conservationxlabs.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID,DNA,MTB 23S rRNA; MTB IS6110; MTB rpoB gene; MTB sdaA gene,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Oropharyngeal swab,NA,90,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Mylab Discovery Solutions Pvt ltd.,a2r69000007lbEz,Mylab PathoDetect MTB Detection kit,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://mylabdiscoverysolutions.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB IS6110,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Sputum; Sputum Culture; Other,EPTB specimen,80,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,india(?!.*ocea),India
Mylab Discovery Solutions Pvt ltd.,a2r69000007lbF0,Mylab PathoDetect MTB RIF and INH resistance detection kit,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://mylabdiscoverysolutions.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,Unknown,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Sputum; Sputum Culture; Other,EPTB specimen,80,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,india(?!.*ocea),India
Molbio Diagnostics Pvt ltd.,a2r69000007lb68,Truenat MTB-BDQ,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://molbiodiagnostics.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Not applicable,qPCR,Fluorescence,atpE,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,india(?!.*ocea),India
Molbio Diagnostics Pvt ltd.,a2r69000007lb67,Truenat MTB-FQ,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://molbiodiagnostics.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Not applicable,qPCR,Fluorescence,gyrA,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,india(?!.*ocea),India
Beckman Coulter Inc.,a2r69000007lbL5,T cell activation marker (TAM-TB) assay,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,North America,https://beckmancoulter.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Immunoassay,ID,Antigen,Other,Flow Cytometry,Fluorescence,Not applicable,Other,Flow cytometry,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Beckman Coulter Inc.,a2r69000007lbL5,T cell activation marker (TAM-TB) assay,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,North America,https://beckmancoulter.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Immunoassay,ID,Antigen,Other,Flow Cytometry,Fluorescence,Not applicable,Other,Flow cytometry,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
LSI Medience Corporation,a2r69000007lbL9,PATHFAST-LAM,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://www.medience.co.jp/english/,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,japan,Japan
Mologic ltd.,a2r69000007lbLE,gLAMexpress,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Europe,https://mologic.co.uk,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Lipoarabinomannan (LAM),Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?kingdom|britain|^u\.?k\.?$,United Kingdom
"Akonni Biosystems, Inc.",a2r69000007lbEn,TruArray MDR-TB,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,North America,https://akonni.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS1245; MTB IS6110,Hybridization,Colorimetric,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Boditech Med.,a2r69000007lbTQ,ichroma CRP,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://boditech.co.kr/en,Health Canada; India CDSCO; US FDA 510k,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Not applicable,Antigen,C-reactive protein,Lateral Flow Assay,Fluorescence,Not applicable,Rapid diagnostic test (strip or cassette),NA,A proprietary/new instrument is required,Manual,near Point of Care,Intended for professional use only,Plasma; Serum; Whole Blood,NA,3,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Molbio Diagnostics Pvt ltd.,a2r69000007lb6D,Truenat MTB-RIF,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://molbiodiagnostics.com,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,rpoB,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Rifampicin,NA,Active TB,84.20%,62.40%,94.50%,95.20%,90.80%,97.50%,0,india(?!.*ocea),India
Molbio Diagnostics Pvt ltd.,a2r69000007lb6D,Truenat MTB-RIF,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://molbiodiagnostics.com,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,rpoB,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Rifampicin,NA,Active TB,81.60%,66.60%,90.80%,97.80%,94.40%,99.10%,218,india(?!.*ocea),India
Molbio Diagnostics Pvt ltd.,a2r69000007lb8k,Truenat MTB,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://molbiodiagnostics.com,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB nrdB gene,qPCR,Fluorescence,Not applicable,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Not applicable,NA,Active TB,91.10%,0.00%,0.00%,100.00%,0.00%,0.00%,226,india(?!.*ocea),India
Molbio Diagnostics Pvt ltd.,a2r69000007lb6E,Truenat MTB-INH,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://molbiodiagnostics.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Fluorescence,inhA; katG,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Isoniazid,NA,Active TB,100.00%,0.00%,0.00%,96.15%,0.00%,0.00%,50,india(?!.*ocea),India
Molbio Diagnostics Pvt ltd.,a2r69000007lb8l,Truenat MTB plus,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://molbiodiagnostics.com,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB IS6110; MTB nrdz gene,qPCR,Fluorescence,Not applicable,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Not applicable,NA,Active TB,79.80%,74.50%,84.30%,96.50%,95.20%,97.40%,1654,india(?!.*ocea),India
ELITechGroup,a2r69000007lbF9,MDR/MTB ELITe InGenius platform,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://elitechgroup.com,Brazil ANVISA; CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
ELITechGroup,a2r69000007lbF9,MDR/MTB ELITe InGenius platform,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://elitechgroup.com,Brazil ANVISA; CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
ELITechGroup,a2r69000007lbFA,MTB EXTRA ELITe InGenius platform,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://elitechgroup.com,Brazil ANVISA; CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB IS6110,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
ELITechGroup,a2r69000007lbFA,MTB EXTRA ELITe InGenius platform,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://elitechgroup.com,Brazil ANVISA; CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB IS6110,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
Nipro Corporation,a2r69000007lb69,Genoscholar PZA-TB II,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://nipro.co.jp,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Colorimetric,pncA,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Pyrazinamide,NA,Active TB,81.20%,75.40%,85.80%,97.80%,96.50%,98.60%,0,japan,Japan
Nipro Corporation,a2r69000007lb69,Genoscholar PZA-TB II,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://nipro.co.jp,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Colorimetric,pncA,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Pyrazinamide,NA,Active TB,96.40%,93.30%,98.40%,100.00%,99.40%,100.00%,0,japan,Japan
Nipro Corporation,a2r69000007lb69,Genoscholar PZA-TB II,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://nipro.co.jp,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Colorimetric,pncA,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Pyrazinamide,NA,Active TB,95.70%,93.50%,97.20%,98.60%,97.40%,99.20%,0,japan,Japan
Nipro Corporation,a2r69000007lbll,Genoscholar FQ+KM-TB II,Regulatory Status Unknown,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://nipro.co.jp,Unknown,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Prediction AST,DNA,Not applicable,qPCR,Colorimetric,gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,japan,Japan
Nipro Corporation,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://nipro.co.jp,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Rifampicin,NA,Active TB,0.00%,75.00%,100.00%,0.00%,96.50%,100.00%,0,japan,Japan
Nipro Corporation,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://nipro.co.jp,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Isoniazid,NA,Active TB,0.00%,50.00%,94.90%,0.00%,96.50%,97.80%,0,japan,Japan
Nipro Corporation,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://nipro.co.jp,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Rifampicin,NA,Active TB,0.00%,92.80%,98.90%,0.00%,97.30%,98.20%,0,japan,Japan
Nipro Corporation,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://nipro.co.jp,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Isoniazid,NA,Active TB,0.00%,61.60%,91.60%,0.00%,99.40%,100.00%,0,japan,Japan
Roche Diagnostics GmbH,a2r69000007lb6A,Roche cobas MTB-RIF/INH,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Not applicable,qPCR,Fluorescence,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Rifampicin,NA,Active TB,96.70%,91.70%,99.10%,97.90%,95.80%,99.20%,0,switz|swiss,Switzerland
Roche Diagnostics GmbH,a2r69000007lb6A,Roche cobas MTB-RIF/INH,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Not applicable,qPCR,Fluorescence,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Isoniazid,NA,Active TB,97.40%,93.50%,99.30%,99.30%,97.60%,99.90%,0,switz|swiss,Switzerland
Roche Diagnostics GmbH,a2r69000007lb6A,Roche cobas MTB-RIF/INH,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Not applicable,qPCR,Fluorescence,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Rifampicin,NA,Active TB,96.70%,91.70%,99.10%,97.90%,95.80%,99.20%,0,switz|swiss,Switzerland
Roche Diagnostics GmbH,a2r69000007lb6A,Roche cobas MTB-RIF/INH,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Not applicable,qPCR,Fluorescence,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Isoniazid,NA,Active TB,97.40%,93.50%,99.30%,99.30%,97.60%,99.90%,0,switz|swiss,Switzerland
Ustar Biotechnologies (Hangzhou) Ltd.,a2r69000007lb8y,Diagnostic Kit for Mycobacterium Tuberculosis Complex DNA,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Asia,https://en.bioustar.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,Unknown,Isothermal NAT(other),Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,80,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
Boditech Med Inc.,a2r69000007lb93,ichroma IGRA-TB 25,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://www.boditech.co.kr,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,Lateral Flow Assay,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Plasma,Li-Heprin,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
SD BIOSENSOR INC,a2r69000007lbFK,STANDARD M MDR-TB,Research Use Only (RUO),Mycobacterium Tuberculosis,Asia,https://sdbiosensor.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,qPCR,Fluorescence,inhA; katG; rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Sputum,NA,30,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
SD BIOSENSOR INC,a2r69000007lbLC,STANDARD F TB-Feron FIA,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://sdbiosensor.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,Lateral Flow Assay,Fluorescence,Not applicable,Rapid diagnostic test (strip or cassette),NA,A proprietary/new instrument is required,Manual,near Point of Care,Intended for professional use only,Plasma,sensitized whole blood in TB-Feron Tubes,15,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
SD BIOSENSOR INC,a2r69000007lbLB,STANDARD M MTB/NTM,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://sdbiosensor.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID,DNA,MTB IS1081; MTB IS6110,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Unknown,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
SD BIOSENSOR INC,a2r69000007lbLC,STANDARD F TB-Feron FIA,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://sdbiosensor.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,Lateral Flow Assay,Fluorescence,Not applicable,Rapid diagnostic test (strip or cassette),NA,A proprietary/new instrument is required,Manual,near Point of Care,Intended for professional use only,Plasma,sensitized whole blood in TB-Feron Tubes,15,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
SD BIOSENSOR INC,a2r69000007lbLC,STANDARD F TB-Feron FIA,Regulatory Achieved,Mycobacterium Tuberculosis,Asia,https://sdbiosensor.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,Lateral Flow Assay,Fluorescence,Not applicable,Rapid diagnostic test (strip or cassette),NA,A proprietary/new instrument is required,Manual,near Point of Care,Intended for professional use only,Plasma,sensitized whole blood in TB-Feron Tubes,15,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
Epistem Limited,a2r69000007lbF2,Gendrive MTB/RIF ID,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Europe,https://epistem.co.uk,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,Unknown,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?kingdom|britain|^u\.?k\.?$,United Kingdom
SD BIOSENSOR INC,a2r69000007lb8x,STANDARD M XDR-TB,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://sdbiosensor.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,Unknown,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Unknown,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*d.*p.*r)(?!.*democrat)(?!.*dem.*rep)(?!.*people)(?!.*north).*\bkorea(?!.*d.*p.*r)(?!.*dem.*rep),South Korea
bioMrieux,a2r69000007lbL6,VIDAS TB-IGRA,Regulatory Achieved,Mycobacterium Tuberculosis,Europe,https://biomerieux.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,ELISA/EIA,Fluorescence,Not applicable,Other,Reagent strip,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,1020,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
bioMrieux,a2r69000007lbL7,ISIT-TB,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Europe,https://biomerieux.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,ID,RNA,Other,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,60,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
bioMrieux,a2r69000007lbL6,VIDAS TB-IGRA,Regulatory Achieved,Mycobacterium Tuberculosis,Europe,https://biomerieux.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,ELISA/EIA,Fluorescence,Not applicable,Other,Reagent strip,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,1020,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
bioMrieux,a2r69000007lbL7,ISIT-TB,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Europe,https://biomerieux.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,ID,RNA,Other,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,60,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
bioMrieux,a2r69000007lbL7,ISIT-TB,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Europe,https://biomerieux.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,ID,RNA,Other,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,60,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bdep)(?!.*martinique).*france|french.?republic|\bgaul,France
NanoPin,a2r69000007lbFC,Nanodisk-MS2,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,North America,https://ceigateway.com/client-profiles/nanopin-technologies,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,MTB CFP-10,Other,Unspecified,Not applicable,Unspecified,NA,Standard lab instrumentation is required,Unknown,Lab-based,Intended for professional use only,Serum,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
LumiraDx,a2r69000007lbAY,LumiraDx MTB qSTAR Test,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Europe,https://lumiradx.com/us-en/what-we-do/diagnostics/fast-lab-solutions,None,NA,2023,Triage/Screening,Molecular,ID,DNA,Unknown,qPCR,Electrochemical,Not applicable,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Other,tongue,15,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?kingdom|britain|^u\.?k\.?$,United Kingdom
Quanterix,a2r69000007lbLG,Simoa SR-X,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,North America,https://quanterix.com,Unknown,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Other,Other,Fluorescence,Not applicable,Unspecified,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb97,Xpert MTB Host Response assay,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,North America,https://cepheid.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,ID-Prediction AST,RNA,MTB DUSP3; MTB GBP5; MTB KLF2,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Quanterix,a2r69000007lbLG,Simoa SR-X,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,North America,https://quanterix.com,Unknown,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Other,Other,Fluorescence,Not applicable,Unspecified,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb97,Xpert MTB Host Response assay,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,North America,https://cepheid.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,ID-Prediction AST,RNA,MTB DUSP3; MTB GBP5; MTB KLF2,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb97,Xpert MTB Host Response assay,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,North America,https://cepheid.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,ID-Prediction AST,RNA,MTB DUSP3; MTB GBP5; MTB KLF2,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
QIAGEN GmbH,a2r69000007lbFF,QuantiFERON-TB Gold Plus (QFT-Plus),Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://www.qiagen.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,Blood stimulation tubes,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
MARTI TB Diagnostics,a2r69000007lb8u,MARTI point-of-care TB diagnostic test,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Africa,https://martidiagnostic.com,None,NA,Unknown,Triage/Screening,Molecular,ID,Antibody (serological),Unknown,Other,Electrochemical,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,south.africa|s\\..?africa,South Africa
QuantuMDx Group Limited,a2r69000007lb90,Q-POC - TB Assay,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,Europe,https://quantumdx.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID,DNA,Unknown,qPCR,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Unknown,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?kingdom|britain|^u\.?k\.?$,United Kingdom
Quanterix,a2r69000007lbLG,Simoa SR-X,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,North America,https://quanterix.com,Unknown,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Other,Other,Fluorescence,Not applicable,Unspecified,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Isoniazid,NA,Active TB,95.20%,92.90%,96.80%,95.60%,90.10%,98.10%,596,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Fluoroquinolone,NA,Active TB,94.50%,90.70%,96.90%,95.20%,92.50%,96.90%,594,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Amikacin,NA,Active TB,87.70%,77.50%,93.60%,98.50%,97.00%,99.20%,593,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Kanamycin,NA,Active TB,93.70%,89.00%,96.40%,92.40%,89.40%,94.60%,594,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Capreomycin,NA,Active TB,75.40%,64.00%,84.00%,99.60%,98.60%,99.90%,595,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Ethionamide,NA,Active TB,55.00%,49.50%,60.30%,93.80%,90.30%,96.10%,597,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Isoniazid,NA,Active TB,95.20%,92.90%,96.80%,95.60%,90.10%,98.10%,596,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Fluoroquinolone,NA,Active TB,94.50%,90.70%,96.90%,95.20%,92.50%,96.90%,594,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Amikacin,NA,Active TB,87.70%,77.50%,93.60%,98.50%,97.00%,99.20%,593,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Kanamycin,NA,Active TB,93.70%,89.00%,96.40%,92.40%,89.40%,94.60%,594,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Capreomycin,NA,Active TB,75.40%,64.00%,84.00%,99.60%,98.60%,99.90%,595,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Cepheid,a2r69000007lb96,Xpert MTB/XDR,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://cepheid.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,qPCR,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Ethionamide,NA,Active TB,55.00%,49.50%,60.30%,93.80%,90.30%,96.10%,597,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,76.50%,63.30%,86.00%,99.10%,97.30%,99.70%,1921,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,87.00%,38.10%,98.60%,99.50%,93.60%,100.00%,1639,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Fluoroquinolone,NA,Active TB,85.60%,79.20%,90.40%,98.50%,95.70%,99.50%,2233,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Fluoroquinolone,NA,Active TB,86.20%,74.60%,93.00%,98.60%,96.90%,99.40%,1771,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,76.50%,63.30%,86.00%,99.10%,97.30%,99.70%,1921,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,87.00%,38.10%,98.60%,99.50%,93.60%,100.00%,1639,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,XDR-TB resistance,Active TB,70.90%,42.90%,88.80%,98.80%,96.10%,99.60%,880,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,XDR-TB resistance,Active TB,69.40%,38.80%,89.00%,99.40%,95.00%,99.30%,1420,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,76.50%,63.30%,86.00%,99.10%,97.30%,99.70%,1921,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,87.00%,38.10%,98.60%,99.50%,93.60%,100.00%,1639,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Fluoroquinolone,NA,Active TB,85.60%,79.20%,90.40%,98.50%,95.70%,99.50%,2233,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Fluoroquinolone,NA,Active TB,86.20%,74.60%,93.00%,98.60%,96.90%,99.40%,1771,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,76.50%,63.30%,86.00%,99.10%,97.30%,99.70%,1921,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,87.00%,38.10%,98.60%,99.50%,93.60%,100.00%,1639,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,XDR-TB resistance,Active TB,70.90%,42.90%,88.80%,98.80%,96.10%,99.60%,880,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8m,GenoType MTBDRsl version 1,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Discontinued,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,embB; gyrA; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,XDR-TB resistance,Active TB,69.40%,38.80%,89.00%,99.40%,95.00%,99.30%,1420,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Not applicable,NA,Active TB,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Fluoroquinolone,NA,Active TB,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Not applicable,NA,Active TB,98.80%,0.00%,0.00%,89.60%,0.00%,0.00%,331,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Fluoroquinolone,NA,Active TB,93.10%,0.00%,0.00%,100.00%,0.00%,0.00%,251,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Amikacin,NA,Active TB,94.70%,0.00%,0.00%,98.10%,0.00%,0.00%,251,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Capreomycin,NA,Active TB,90.00%,0.00%,0.00%,98.10%,0.00%,0.00%,251,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Kanamycin,NA,Active TB,94.80%,0.00%,0.00%,96.60%,0.00%,0.00%,251,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Not applicable,NA,Active TB,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Fluoroquinolone,NA,Active TB,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Other,SLID resistance,Active TB,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Not applicable,NA,Active TB,98.80%,0.00%,0.00%,89.60%,0.00%,0.00%,331,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Fluoroquinolone,NA,Active TB,93.10%,0.00%,0.00%,100.00%,0.00%,0.00%,251,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Amikacin,NA,Active TB,94.70%,0.00%,0.00%,98.10%,0.00%,0.00%,251,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Capreomycin,NA,Active TB,90.00%,0.00%,0.00%,98.10%,0.00%,0.00%,251,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8n,GenoType MTBDRsl version 2,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Kanamycin,NA,Active TB,94.80%,0.00%,0.00%,96.60%,0.00%,0.00%,251,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8q,FluoroType XDR VER 1.0,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Unknown,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,embB; gyrA; gyrB; rplC; rrl; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lb8q,FluoroType XDR VER 1.0,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Unknown,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,embB; gyrA; gyrB; rplC; rrl; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
BD Biosciences,a2r69000007lbEq,Blood based active TB test,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,North America,https://bdbiosciences.com/en-us,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Unknown,Flow Cytometry,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,30,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Hain Lifescience GmbH,a2r69000007lb8q,FluoroType XDR VER 1.0,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Unknown,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,embB; gyrA; gyrB; rplC; rrl; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
QIAGEN GmbH,a2r69000007lbFG,LIAISON QuantiFERON-TB Gold Plus assay,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://www.qiagen.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,MTB CFP-10; MTB ESAT-6,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
QIAGEN GmbH,a2r69000007lbFG,LIAISON QuantiFERON-TB Gold Plus assay,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://www.qiagen.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,MTB CFP-10; MTB ESAT-6,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
QIAGEN GmbH,a2r69000007lbLF,QIAReach QuantiFERON-TB,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://www.qiagen.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,Lateral Flow Assay,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Whole Blood,NA,1440,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
QIAGEN GmbH,a2r69000007lbFG,LIAISON QuantiFERON-TB Gold Plus assay,Regulatory Achieved,Mycobacterium Tuberculosis,North America,https://www.qiagen.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,MTB CFP-10; MTB ESAT-6,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Roche Diagnostics GmbH,a2r69000007lbFI,Roche cobas MTB,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB 23S rRNA; Other,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Not applicable,NA,Active TB,98.90%,96.90%,99.70%,98.20%,96.10%,99.30%,0,switz|swiss,Switzerland
Roche Diagnostics GmbH,a2r69000007lbFI,Roche cobas MTB,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID,DNA,MTB 23S rRNA; Other,qPCR,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Not applicable,NA,Active TB,98.90%,96.90%,99.70%,98.20%,96.10%,99.30%,0,switz|swiss,Switzerland
Hain Lifescience GmbH,a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,NA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Rifampicin,NA,Active TB,96.80%,94.70%,98.10%,98.10%,96.90%,98.80%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,NA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Isoniazid,NA,Active TB,88.40%,84.40%,91.60%,98.30%,97.40%,98.90%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,NA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Rifampicin,NA,Active TB,97.30%,95.70%,98.30%,99.50%,98.80%,98.80%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,NA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Isoniazid,NA,Active TB,91.50%,89.00%,93.50%,99.80%,99.30%,100.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,NA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Rifampicin,NA,Active TB,96.80%,94.70%,98.10%,98.10%,96.90%,98.80%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,NA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Isoniazid,NA,Active TB,88.40%,84.40%,91.60%,98.30%,97.40%,98.90%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,NA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Rifampicin,NA,Active TB,97.30%,95.70%,98.30%,99.50%,98.80%,98.80%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,NA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Isoniazid,NA,Active TB,91.50%,89.00%,93.50%,99.80%,99.30%,100.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEu,FluoroType MTBDR VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEu,FluoroType MTBDR VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Rifampicin,NA,Active TB,95.80%,92.60%,97.60%,98.40%,96.90%,99.20%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Isoniazid,NA,Active TB,94.50%,91.40%,96.50%,99.30%,92.60%,100.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Rifampicin,NA,Active TB,91.30%,0.00%,0.00%,98.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Isoniazid,NA,Active TB,89.40%,0.00%,0.00%,98.90%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEu,FluoroType MTBDR VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbF1,FluoroType Mycobacteria VER 1.0 PCR Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Rifampicin,NA,Active TB,95.80%,92.60%,97.60%,98.40%,96.90%,99.20%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Isoniazid,NA,Active TB,94.50%,91.40%,96.50%,99.30%,92.60%,100.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Rifampicin,NA,Active TB,91.30%,0.00%,0.00%,98.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB 23S rRNA,Hybridization,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Isoniazid,NA,Active TB,89.40%,0.00%,0.00%,98.90%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbF1,FluoroType Mycobacteria VER 1.0 PCR Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Hain Lifescience GmbH,a2r69000007lbF1,FluoroType Mycobacteria VER 1.0 PCR Kit,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Europe,https://hain-lifescience.de/en/,CE-IVDD; Other,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB IS6110,qPCR,Colorimetric,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
Generium,a2r69000007lbF3,Diaskintest,Regulatory Status Unknown,Mycobacterium Tuberculosis,Europe,https://generium.ru/en,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,MTB CFP-10; MTB ESAT-6,Host Immune Response,Colorimetric,Not applicable,Other,Injectable,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Other,injection under skin,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,\brussia|soviet.?union|u\.?s\.?s\.?r|socialist.?republics,Russia
Leiden Unversity Medical Center,a2r69000007lbEw,TB Triage multiplex LFA,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,Europe,https://lumc.nl,None,NA,Unknown,Triage/Screening,Immunoassay,ID,Antigen,Unknown,Lateral Flow Assay,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,near Point of Care,Intended for professional use only,Finger prick blood,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bant)(?!.*\bcarib).*netherlands,Netherlands
LIONEX Diagnostics & Therapeutics GmbH,a2r69000007lbEx,LIOFeron TB/LTBI IGRA; HUMAN IFN-?ELISA KIT,Regulatory Achieved,Mycobacterium Tuberculosis,Europe,https://lionex.de,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,Blood stimulation tubes,1440,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*east).*germany|^(?=.*\bfed.*\brep).*german,Germany
LG Chem Life Sciences Company,a2r69000007lb8v,AdvanSure TB-IGRA ELISA,Research Use Only (RUO),Mycobacterium Tuberculosis,North America,https://innovation.lgchem.com,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ID,Antigen,Interferon Gamma,ELISA/EIA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,heprin,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?states\b(?!.*islands)|\bu\.?s\.?a\.?\b|^\s*u\.?s\.?\b(?!.*islands),United States
Life Arc,a2r69000007lb8s,TB-MBLA,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Europe,https://lifearc.org,None,NA,2023,"Monitoring (treatment, immune status, patient)",Molecular,ID,RNA,MTB 23S rRNA,qPCR,Fluorescence,Not applicable,NAT reagent kit (open source),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum,NA,300,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,united.?kingdom|britain|^u\.?k\.?$,United Kingdom
CapitalBio Technology,a2r69000007lbF7,Genechip MDR kit,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://capitalbiotech.com/en/index.html,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,Unknown,Other,Fluorescence,inhA; katG; rpoB,Cartridge-based processing,microarray chip based,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
"Bao Ruiyuan Biotech(Beijing) Co.,ltd.",a2r69000007lbEp,Mycobacterium Tuberculosis and Drug Resistance Gene Rapid NAT Test Kit,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,Asia,https://abiores.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,ID-Prediction AST,DNA,MTB H37Rv gene,qPCR,Fluorescence,embB; gyrA; gyrB; inhA; katG; rpoB; rpsL,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Sputum,NA,60,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,^(?!.*\bmac)(?!.*\bhong)(?!.*\btai)(?!.*\brep).*china|^(?=.*peo)(?=.*rep).*china,China
Molbio Diagnostics Pvt ltd.,a2r69000007ISZj,Truenat Positive Control Kit - Panel I,Regulatory Achieved,Influenza A; Mycobacterium Tuberculosis; SARS-CoV-2,Asia,https://molbiodiagnostics.com,CE-IVDD,NA,Already on the market (commercialized),Quality Control/Validation,Molecular,ID,RNA,Unknown,NA,NA,Not applicable,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,NA,NA,NA,0.00%,0.00%,0.00%,0.00%,0.00%,0.00%,0,india(?!.*ocea),India
